The Latest
-
5 things to watch on the ASX 200 on Wednesday
-
Sorrento’s COVID-19 Antidote Could be a Game Changer, Says Analyst
-
Market Recap: Tuesday, May 26
-
Column: Moderna execs sold $29 million in stock after its early vaccine announcement